Literature DB >> 9333094

Use of antibiotic-impregnated polymethyl methacrylate in horses with open or infected fractures or joints: 19 cases (1987-1995).

S J Holcombe1, R K Schneider, L R Bramlage, R M Embertson.   

Abstract

OBJECTIVE: To evaluate the clinical efficacy of antibiotic-impregnated polymethyl methacrylate (PMMA) in horses with open or infected fractures or joints in which internal fixation or external coaptation devices were used.
DESIGN: Retrospective case series. ANIMALS: 19 horses in which antibiotic-impregnated PMMA was used as part of the treatment regimen. PROCEDURES: Medical records of each horse were reviewed, and owners and trainers were contacted to provide additional information.
RESULTS: Musculoskeletal problems in these horses included 10 fractures of long bones, 2 comminuted phalangeal fractures, 5 joint injuries, and 2 chronically septic joints in which ankylosis was stimulated. Nine horses had open fractures, 8 had closed wounds and developed infection after internal fixation of fractures, and 2 had chronically septic joints. Bony union was achieved in 15 of 19 horses. Twelve horses were discharged from the hospital and survived long term. Gentamicin sulfate, tobramycin sulfate, amikacin sulfate, and cefazolin sodium were used in PMMA. CLINICAL IMPLICATIONS: Use of antibiotic-impregnated PMMA provided high local concentrations of antibiotics and should be considered in the treatment of horses with open fractures and acute and chronic bone and joint infections.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9333094

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  2 in total

1.  Arthrodesis of the proximal interphalangeal joint affected with septic arthritis in 8 horses.

Authors:  L J Groom; E M Gaughan; J D Lillich; L W Valentino
Journal:  Can Vet J       Date:  2000-02       Impact factor: 1.008

2.  Efficacy of antibiotic-impregnated polymethylmethacrylate beads in a rhesus macaque (Macaca mulatta) with osteomyelitis.

Authors:  Kristi R Kelly; Amy R Kapatkin; Allison L Zwingenberger; Kari L Christe
Journal:  Comp Med       Date:  2012-08       Impact factor: 0.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.